Caris Life Sciences, Inc. (CAI)
28.30
-0.05
(-0.18%)
USD |
NASDAQ |
Oct 02, 16:00
28.44
+0.14
(+0.49%)
After-Hours: 20:00
Caris Life Sciences Price : 28.30 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 28.72 | 28.97 | 28.07 | 28.30 | 3.205M |
| Oct 01, 2026 | 30.60 | 30.96 | 28.29 | 28.35 | 4.407M |
| Sep 30, 2026 | 31.40 | 32.04 | 30.60 | 30.63 | 2.930M |
| Sep 29, 2026 | 31.64 | 32.32 | 30.82 | 31.55 | 3.714M |
| Sep 28, 2026 | 31.73 | 32.09 | 30.88 | 31.75 | 3.939M |
| Sep 25, 2026 | 32.65 | 32.77 | 31.58 | 31.98 | 2.919M |
| Sep 24, 2026 | 31.34 | 32.40 | 30.91 | 32.27 | 5.982M |
| Sep 23, 2026 | 31.12 | 32.89 | 31.10 | 31.65 | 4.360M |
| Sep 22, 2026 | 31.55 | 32.36 | 31.33 | 31.47 | 5.960M |
| Sep 21, 2026 | 30.23 | 30.71 | 29.97 | 30.65 | 6.147M |
| Sep 18, 2026 | 30.29 | 30.99 | 29.69 | 29.98 | 14.72M |
| Sep 17, 2026 | 28.60 | 31.36 | 28.53 | 30.92 | 7.662M |
| Sep 16, 2026 | 28.16 | 29.08 | 27.91 | 28.21 | 4.303M |
| Sep 15, 2026 | 25.80 | 28.68 | 25.80 | 28.50 | 8.842M |
| Sep 14, 2026 | 24.24 | 26.18 | 24.05 | 26.05 | 3.642M |
| Sep 11, 2026 | 24.16 | 24.67 | 24.09 | 24.34 | 1.823M |
| Sep 10, 2026 | 23.20 | 24.68 | 23.20 | 24.04 | 2.629M |
| Sep 09, 2026 | 24.00 | 24.96 | 23.95 | 24.03 | 3.147M |
| Sep 08, 2026 | 25.03 | 25.68 | 24.74 | 24.82 | 4.584M |
| Sep 04, 2026 | 24.88 | 25.14 | 24.47 | 25.07 | 4.711M |
| Sep 03, 2026 | 24.94 | 25.34 | 23.62 | 25.32 | 6.432M |
| Sep 02, 2026 | 25.13 | 25.62 | 24.50 | 24.80 | 5.488M |
| Sep 01, 2026 | 25.60 | 25.62 | 24.55 | 24.78 | 4.027M |
| Aug 31, 2026 | 25.35 | 25.56 | 24.48 | 25.49 | 5.868M |
| Aug 28, 2026 | 26.15 | 26.75 | 25.47 | 25.63 | 3.835M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CareDx, Inc. | 67.15 |
| Natera, Inc. | 410.35 |
| Myriad Genetics, Inc. | 4.54 |
| BioRestorative Therapies, Inc. | 2.14 |
| Exagen, Inc. | 8.17 |
Price Related Metrics
| PE Ratio | 76.01 |
| PS Ratio | 8.079 |
| Price to Book Value | 13.51 |
| Price to Free Cash Flow | 68.78 |
| Earnings Yield | 1.32% |
| Market Cap | 7.997B |
| Operating PE Ratio | 52.17 |
| Normalized PE Ratio | 63.64 |